Inherent risks associated with manufacture of bioengineered ocular surface tissue.

@article{Schwab2006InherentRA,
  title={Inherent risks associated with manufacture of bioengineered ocular surface tissue.},
  author={Ivan R. Schwab and Nigel T Johnson and Damien G. Harkin},
  journal={Archives of ophthalmology},
  year={2006},
  volume={124 12},
  pages={1734-40}
}
OBJECTIVE To review the potential health risks associated with bioengineered ocular surface tissue, which serves as a bellwether for other tissues. METHODS All clinical trials using bioengineered ocular surface tissue published between July 1, 1996, and June 30, 2005, were reviewed with respect to materials used and statements of risk assessment, risk remediation, adverse events, manufacturing standards, and regulatory oversight. RESULTS Ninety-five percent of investigational protocols used… CONTINUE READING

From This Paper

Figures and tables from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 33 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 58 references

Degrees and kinds of selection in spontaneous neoplastic transformation: an operational analysis.

Proceedings of the National Academy of Sciences of the United States of America • 2005

Similar Papers

Loading similar papers…